Ultra-Deep DNA Methylation Analysis of X-Linked Genes:


Journal

Genes
ISSN: 2073-4425
Titre abrégé: Genes (Basel)
Pays: Switzerland
ID NLM: 101551097

Informations de publication

Date de publication:
04 06 2020
Historique:
received: 22 04 2020
revised: 28 05 2020
accepted: 02 06 2020
entrez: 10 6 2020
pubmed: 10 6 2020
medline: 20 3 2021
Statut: epublish

Résumé

Recessive X-linked disorders may occasionally evolve in clinical manifestations of variable severity also in female carriers. For some of such diseases, the frequency of the symptoms' appearance during women's life may be particularly relevant. This phenomenon has been largely attributed to the potential skewness of the X-inactivation process leading to variable phenotypes. Nonetheless, in many cases, no correlation with X-inactivation unbalance was demonstrated. However, methods for analyzing skewness have been mainly limited to Human Androgen Receptor methylation analysis (HUMARA). Recently, the X-inactivation process has been largely revisited, highlighting the heterogeneity existing among loci in the epigenetic state within inactive and, possibly, active X-chromosomes. We reasoned that gene-specific and ultra-deep DNA methylation analyses could greatly help to unravel details of the X-inactivation process and the roles of specific X genes inactivation in disease manifestations. We recently provided evidence that studying DNA methylation at specific autosomic loci at a single-molecule resolution (epiallele distribution analysis) allows one to analyze cell-to-cell methylation differences in a given cell population. We here apply the epiallele analysis at two X-linked loci to investigate whether females show allele-specific epiallelic patterns. Due to the high potential of this approach, the method allows us to obtain clearly distinct allele-specific epiallele profiles.

Identifiants

pubmed: 32512878
pii: genes11060620
doi: 10.3390/genes11060620
pmc: PMC7349208
pii:
doi:

Substances chimiques

AR protein, human 0
Receptors, Androgen 0
GLA protein, human EC 3.2.1.22
alpha-Galactosidase EC 3.2.1.22

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Genet Med. 2007 Jan;9(1):34-45
pubmed: 17224688
Proc Natl Acad Sci U S A. 2018 Dec 18;115(51):13015-13020
pubmed: 30510006
Epigenetics. 2015;10(9):810-8
pubmed: 26178744
Biochem Soc Trans. 2018 Jun 19;46(3):577-586
pubmed: 29678955
Semin Cell Dev Biol. 2016 Aug;56:78-87
pubmed: 26994527
Eur J Hum Genet. 2014 Dec;22(12):1376-81
pubmed: 24713664
BMC Bioinformatics. 2016 Nov 25;17(1):484
pubmed: 27884103
Am J Hum Genet. 1992 Dec;51(6):1229-39
pubmed: 1281384
Genome Biol. 2014 Sep 27;15(9):472
pubmed: 25260792
Sci Rep. 2018 Jul 5;8(1):10163
pubmed: 29976992
J Mol Cell Biol. 2015 Feb;7(1):2-11
pubmed: 25564545
J Clin Invest. 2008 Jan;118(1):20-3
pubmed: 18097476
Hum Mol Genet. 2018 Aug 1;27(R2):R242-R249
pubmed: 29701779
Clin Epigenetics. 2019 Oct 28;11(1):149
pubmed: 31661019
Genome Res. 2011 Oct;21(10):1592-600
pubmed: 21862626
Epigenetics. 2016 Dec;11(12):881-888
pubmed: 27748645
Science. 2018 Sep 28;361(6409):
pubmed: 30139913
Clin Genet. 2004 Oct;66(4):327-32
pubmed: 15355435
Hum Mol Genet. 2015 Mar 15;24(6):1528-39
pubmed: 25381334
Genome Res. 1998 Mar;8(3):175-85
pubmed: 9521921
Nat Genet. 2017 May;49(5):719-729
pubmed: 28346445
Genome Biol. 2010;11(6):213
pubmed: 20573260
Epigenetics. 2017 Jan 2;12(1):41-54
pubmed: 27858532

Auteurs

Giulia De Riso (G)

Department of Molecular Medicine and Medical Biotechnology, Università degli Studi di Napoli 'Federico II', Via S. Pansini, 5, 80131 Naples, Italy.

Mariella Cuomo (M)

Department of Molecular Medicine and Medical Biotechnology, Università degli Studi di Napoli 'Federico II', Via S. Pansini, 5, 80131 Naples, Italy.
CEINGE Biotecnologie Avanzate, via Gaetano Salvatore 482, 80145 Naples, Italy.

Teodolinda Di Risi (T)

CEINGE Biotecnologie Avanzate, via Gaetano Salvatore 482, 80145 Naples, Italy.
Department of Sanità Pubblica, Università degli Studi di Napoli 'Federico II', Via S. Pansini, 5, 80131 Naples, Italy.

Rosa Della Monica (R)

CEINGE Biotecnologie Avanzate, via Gaetano Salvatore 482, 80145 Naples, Italy.

Michela Buonaiuto (M)

Department of Molecular Medicine and Medical Biotechnology, Università degli Studi di Napoli 'Federico II', Via S. Pansini, 5, 80131 Naples, Italy.
CEINGE Biotecnologie Avanzate, via Gaetano Salvatore 482, 80145 Naples, Italy.

Davide Costabile (D)

Department of Molecular Medicine and Medical Biotechnology, Università degli Studi di Napoli 'Federico II', Via S. Pansini, 5, 80131 Naples, Italy.
CEINGE Biotecnologie Avanzate, via Gaetano Salvatore 482, 80145 Naples, Italy.

Antonio Pisani (A)

Department of Sanità Pubblica, Università degli Studi di Napoli 'Federico II', Via S. Pansini, 5, 80131 Naples, Italy.

Sergio Cocozza (S)

Department of Molecular Medicine and Medical Biotechnology, Università degli Studi di Napoli 'Federico II', Via S. Pansini, 5, 80131 Naples, Italy.

Lorenzo Chiariotti (L)

Department of Molecular Medicine and Medical Biotechnology, Università degli Studi di Napoli 'Federico II', Via S. Pansini, 5, 80131 Naples, Italy.
CEINGE Biotecnologie Avanzate, via Gaetano Salvatore 482, 80145 Naples, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH